Midwest Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.05M Sell
116,266
-4,106
-3% -$239K 0.09% 180
2025
Q4
$6.49M Sell
120,372
-1,424
-1% -$68.5K 0.08% 183
2025
Q3
$5.49M Sell
121,796
-713
-0.6% -$33.3K 0.07% 202
2025
Q2
$5.67M Buy
+122,509
New +$6.01M 0.08% 190

Other funds holding BMY

Midwest Trust's BMY Position: Q1 2026 in Review

Midwest Trust reduced its Bristol-Myers Squibb (BMY) stake by 3.4% in Q1 2026, selling an estimated $239K and leaving 116,266 shares worth $7.05M. The position accounts for 0.09% of the portfolio, ranked #180.

Midwest Trust first reported a position in BMY in Q2 2025 and has held it in 4 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Midwest Trust held 116,266 shares of Bristol-Myers Squibb worth $7.05M as of Q1 2026.
  • Midwest Trust sold 4,106 Bristol-Myers Squibb shares in Q1 2026, an estimated $239K.
  • Bristol-Myers Squibb made up 0.09% of Midwest Trust's portfolio in Q1 2026, its #180 holding.
  • Midwest Trust first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 4 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Midwest Trust's 13F filing for Q1 2026, filed 1 May 2026.